United Kingdom· GB-APID-39130811000001100
Zeposia 0.23mg/0.46mg capsules treatment initiation pack
A medicinal product containing ozanimod, registered in United Kingdom by Bristol-Myers Squibb Pharmaceuticals Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Ozanimod
- Manufacturer
- Bristol-Myers Squibb Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5065000521394
- gtin05065000521394
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ozanimod in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsZeposia 0,23 mg capsule, hardBristol-Myers Squibb Pharma EEIG
- NorwayZeposiaBristol-Myers Squibb Pharma EEIG (1)
- SwitzerlandZeposia 0.23 mg, HartkapselnBristol-Myers Squibb SA
- CzechiaZEPOSIABristol-Myers Squibb Pharma EEIG, Dublin
- IcelandZeposiaBristol-Myers Squibb Pharma EEIG*
- ItalyZEPOSIA*28 cps 0,92 mgBRISTOL M.SQUIBB PHARMA EEIG
- PolandZeposiaBristol-Myers Squibb Pharma EEIG
- SwedenZeposia 0,23 mg + 0,46 mg Kapsel, hårdBristol-Myers Squibb Pharma EEIG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zeposia
- Liechtenstein · Zeposia
- Norway · Zeposia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c4c452b1-9131-4ef6-ae21-0aed69a0b7a4 GET /v1/drugs/c4c452b1-9131-4ef6-ae21-0aed69a0b7a4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "39130811000001100",
"desc": "Zeposia 0.23mg/0.46mg capsules treatment initiation pack (Bristol-Myers Squibb Pharmaceuticals Ltd)",
"form": "Not applicable",
"vpid": "39149611000001109",
"source": "dmd",
"vtm_id": "871801009",
"strength": null,
"substance": "Ozanimod",
"ingredient": null,
"supplier_code": "3145301000001104"
}See everything about ozanimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.